---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-029799"
form_type: "8-K"
ticker: "COO"
cik: "0000711404"
company_name: "COOPER COMPANIES, INC."
filed_at: "2022-02-07T23:59:59+00:00"
generated_at: "2026-06-27T10:51:58.436246+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CooperCompanies to acquire Cook Medical's Reproductive Health business for $875M

## Summary
- Deal consideration: $675M at closing plus $200M in four $50M annual installments.
- Cook's Reproductive Health had ~$158M revenue in 2021, up ~17% YoY in constant currency.
- Expected to be accretive to non-GAAP EPS by ~$0.60 in the first year after closing.
- Acquisition enhances CooperSurgical's international fertility footprint and ObGyn device portfolio.
- Closing subject to regulatory approvals, definitive agreement, and local consultation requirements.

## SEC filing metadata
- accession: 0001193125-22-029799
- form_type: 8-K
- ticker: COO
- cik: 0000711404
- company_name: COOPER COMPANIES, INC.
- filed_at: 2022-02-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711404/000119312522029799/0001193125-22-029799-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711404/000119312522029799/d310069d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-029799
- JSON: https://secwatch.observer/filing/0001193125-22-029799.json
- Plain text: https://secwatch.observer/filing/0001193125-22-029799.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.